Syntax Research’s Stryker SYK Stock Holding History

Syntax Research’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$627K	Sell	1,991 -9	-0.5%	-$2.84K	0.46%	35
2026 Q1	$657K	Buy	+2,000	New	+$718K	0.42%	45

Other funds holding SYK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Syntax Research's SYK Position: Q2 2026 in Review

Syntax Research reduced its Stryker (SYK) stake by 0.45% in Q2 2026, selling an estimated $2.84K and leaving 1,991 shares worth $627K. The position accounts for 0.46% of the portfolio, ranked #35.

Syntax Research first reported a position in SYK in Q1 2026 and has held it in 2 quarters since. The position peaked at $657K in Q1 2026. 2,259 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

Syntax Research held 1,991 shares of Stryker worth $627K as of Q2 2026.
Syntax Research sold 9 Stryker shares in Q2 2026, an estimated $2.84K.
Stryker made up 0.46% of Syntax Research's portfolio in Q2 2026, its #35 holding.
Syntax Research first reported a position in Stryker in Q1 2026 and has held it in 2 quarters since.
Syntax Research's Stryker position peaked at $657K in Q1 2026.
2,259 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.